comparemela.com

Page 12 - வீட்டுவசதி நிதி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Glenmark Life Share price: Stocks in the news: Glenmark Life, Hindalco, MSI, Cipla, PVR and IB Housing

Glenmark Life Share price: Stocks in the news: Glenmark Life, Hindalco, MSI, Cipla, PVR and IB Housing
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

Market Ahead Podcast, August 6: Top factors that could guide markets today

Market Ahead Podcast, August 6: Top factors that could guide markets today
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

Stocks to watch: M&M, Glenmark Life Sciences, Cipla, Adani Power, Tata Chem

Stocks to watch: M&M, Glenmark Life Sciences, Cipla, Adani Power, Tata Chem
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

Poor sales push real estate firms off the cliff

THE STANDARD REAL ESTATE The mortgage decline in Kenya comes even as the government accelerates its affordable housing programme. [Courtesy] No sooner had the grave of Chris Kirubi dried up than Centum Investment, a company the late tycoon founded, recorded its first loss in four decades. This news must have left the flamboyant billionaire shaking in his grave. But even Kirubi would not be amused was he alive, that one of the most decorated feathers in his investment cap- Two Rivers Mall- contributed to the Sh1.4 billion loss in the year ending March. It is not only Centum that had a rough patch owing to difficulties in the property market. Almost all the listed companies dealing in real estate have been hit hard by the Covid-19 pandemic.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.